PIIINP (N-terminal Propeptide of Procollagen Type III): A Biomarker of Fibrosis and Tissue Remodelling
Introduction and Its Role in Collagen Synthesis
The N-terminal propeptide of type III procollagen (PIIINP) is a marker that gets released while type III collagen is being synthesized – a protein, in tissue repair and remodelling processes, in tissues like skin and internal organs such as the lungs and liver as well as blood vessels. Due to its role in maintaining structural integrity and flexibility of these tissues during collagen production process through cleaving the N-terminal region of the precursor molecule procollagen that leads to the release of PIIINP, into the bloodstream.
PIIINP is an indicator of collagen type III synthesis, in the body; higher levels of this protein in blood or tissue samples often signal increased collagen turnover linked to processes like organ tissue remodelling in areas such as the liver and lungs – making it a key biomarker, for tracking fibrosis development and disease progression management.
Biomarker for Fibrosis and Disease Progression
PIIINP is an indicator, in medical conditions marked by excessive tissue fibrosis such as liver scarring and issues with heart and lung functions due to the buildup of extracellular matrix (ECMs). This builds up leads to scarring and hampers tissue operation in conditions, like liver fibrosis and heart or lung problems caused by the overproduction of ECM disrupting organ functions and leading to disease advancement.
PIIINPs are handy, in settings because they can indicate the presence of fibrotic activity effectively! For example, in liver conditions like steatohepatitis (also known as NASH) or hepatitis C. Higher levels of serum based PIIINP match the severity of liver fibrosis observed. Tracking changes in PIIINP over time helps doctors determine if fibrosis is progressing or reversing course. Guiding treatment decisions accordingly. Furthermore, in patients with heart issues like heart failure, increased levels of serum PIIINP point to the presence of fibrosis that contributes to a decline, in heart function. By monitoring the levels of PIIINP in these individuals we can gain information, about the success of treatments focused on lowering buildup and enhancing heart performance.
In cases of fibrosis (IPF) a lung disease that worsens over time and can be deadly; PIIINP concentrations have been examined as signals of the advancement of the condition. Increased levels of PIIINP, in individuals with IPF are an indication of tissue scarring in the lungs. Could potentially be used as an early warning sign for the course of the illness. Therefore, PIIINP shows potential as a intrusive marker, for keeping track of scarring related conditions affecting various parts of the body.
The Mechanisms of Release in Tissue Remodelling
The presence of a substance called PIIINP is linked to the creation and placement of type III collagen, in the body – a process controlled by fibroblasts and other cell types crucial for healing wounds and repairing tissues. When tissue damage occurs, or inflammation persists over time fibroblasts become activated. Start producing collagen, as collagen fibres are being formed the precursor molecule procollagen is enzymatically broken down at both end N-terminal and C-terminal. This breakdown releases PIIINP into the bloodstream, where it can be detected as an indication of the turnover of collagen, in the body.
The communication routes that control the creation of collagen and the release of PIIINP entail growth factors, like transforming growth factor beta (TGF-β) a promoter of fibrosis. TGF-β prompts fibroblasts to boost the generation of collagen and other components of the matrix (ECM) continuing the cycle of fibrosis. In conditions such as liver cirrhosis or cardiac fibrosis continuous TGF-β signalling triggers collagen production resulting in an increase, in blood levels of PIIINP. The continuous production of ECM leads to the substitution of tissue, with tissue over time which affects organ function detrimentally. The comprehension of these processes underscores the significance of PIIINP, as an indicator of fibrogenic activity and tissue restructuring.
Clinical Applications and Future Directions for Monitoring
Measuring the levels of PIIINP gives doctors a tool to help them diagnose and keep track of the progress of diseases involving scarring tissues, like fibrosis in organs such as the liver and lungs without procedures, like biopsies.
In cases of liver disease serum PIIINP have shown potential as an invasive substitute, for the traditional liver biopsy procedure, which is the current standard for evaluating liver fibrosis but can be risky and uncomfortable for patients. Higher levels of PIIINP are an indicator of liver fibrosis providing an invasive option for initial evaluations and monitoring in individuals, with ongoing liver issues.
In the field of health researchers are investigating whether the levels of a substance called PIIINP can predict results, in heart failure and other diseases linked to heart fibrosis. When patients, with heart failure have levels of PIIINP it is often linked to outcomes because fibrosis can cause the hearts elasticity to decrease and its pumping function to be compromised. Monitoring levels of this substance could help identify patients at risk who may need intense treatments or closer observation.
Suitable ELISA Kits
Online Enquiry Form
"*" indicates required fields
